Cancer Research UK logo.
SearchDonate
  • Search
Researcher pipetting whilst sat at a lab bench and smiling.

Our research into myeloma

Our research is saving lives

Myeloma is a cancer that starts from immune cells in the bone marrow. Around 15 people are diagnosed with the disease each day. Survival is improving all the time – a third of people will now survive their disease for at least 10 years. But we know we need to do better, so our researchers are working hard to save more lives, now and in the future.

Studying samples in the lab.

Current research

From studying the biology of myeloma cells in the lab to leading clinical trials testing cutting-edge treatments, our researchers are working hard to ensure more people survive myeloma.

Find out more about our current research

Inside of a centrifuge.

Past research

Thanks to research, we’ve helped change the outlook for people with myeloma.

Find out more about past research

Explore our timeline of research into myeloma

Our strategy

Over the last 40 years, cancer survival in the UK has doubled. In the 1970s just 1 in 4 people survived their disease for 10 years or more. Today 2 in 4 survive.

We want to accelerate progress and see 3 in 4 patients surviving the disease by 2034.

Read more about our strategy

Clinical trials

Cancer News

Browse the latest news, analysis and opinion from Cancer Research UK.

Further information

Want to find more information about our research or myeloma?

Find out more about clinical trials

More about the symptoms and treatments for myeloma